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Abstract. Desmoid tumors are rarely observed tumors that 
develop from deep muscle and aponeurotic tissues. They are 
histologically intermediate, and exhibit a local aggressive 
course. These tumors have been observed in the abdominal 
region, and are rarely encountered in the thoracic wall. The 
most effective treatment appears to be surgery. A 59-year-old 
female patient was admitted with the complaint of right breast 
pain and a palpable mass. The patient had undergone a modi-
fied radical mastectomy surgical procedure of the right breast 
due to invasive breast carcinoma 10 years before. A mass with 
a soft tissue density and a size of 44x22 mm was detected in 
the thoracic computed tomography of the patient, which subse-
quently resulted in biopsy followed by surgery. As a result of 
the pathological examination of the mass, the diagnosis was 
determined as desmoid tumor. Due to the closeness of the 
tumor to the surgical margin, the patient was administered 
radiotherapy and maintenance imatinib treatment was started.
Introduction
Desmoid tumors are rare tumors, which constitute only 0.3% 
of solid tumors and 3% of all soft tissue tumors (1). This tumor, 
with an incidence of 2-4/million, is also known as aggressive 
fibromatosis and desmoid‑type fibromatosis (2). In addition 
to an intra-abdominal location, which is the most frequently 
involved region, it also exhibits thoracic wall involvement 
at a rate of 10-28% (3). The current study reports a patient 
presenting a rare case of desmoid tumor with an extra-abdom-
inal location and a history of mastectomy due to breast cancer.
Case report
The 59-year-old female patient was admitted due to an 
increasing pain in the right thoracic region over 2 months and 
a palpable mass under the ribcage. The patient history revealed 
that the patient had undergone a modified radical mastectomy 
of the right breast due to invasive breast carcinoma 10 years 
prior and adjuvant chemotherapy and radiotherapy were 
administered following the diagnosis of stage III disease. A 
thorax computed tomography for the mass was requested from 
the patient, who used an aromatase inhibitor and was followed 
up due to breast cancer (Figs. 1 and 2). Upon the detection of a 
44x22 mm mass in the 7th and 8th right intercostal spaces as 
a result of the tomography, a transthoracic fine needle biopsy 
was applied. As a result of the biopsy, a mesenchymal tumor 
was diagnosed. In the cross section of the en-bloc resection, 
the lesion was poorly circumscribed with infiltration of the 
soft tissue structures and bone. It was characterized by prolif-
eration of elongated, slender, spindle-shaped cells of uniform 
appearance. The cells were arranged in long sweeping bundles 
(Fig. 3A). The tumor cells were immunohistochemically 
stained with vimentin, smooth muscle actin and cluster of 
differentiation 117 (CD117) focal positive (Fig. 3B). The mass 
was conclusively diagnosed as a desmoid tumor. Due to the 
closeness to the surgical margin, the patient was administered 
60 Gy curative radiotherapy and oral maintenance imatinib 
treatment was started. The patient is currently in the second 
year of follow-up and maintenance imatinib treatment is 
continuing. The control images of the patient did not detect 
any relapse.
Discussion
A desmoid tumor is a proliferative disease of the fibrous tissue 
arising from deep muscle and aponeuroses. This tumor is 
observed twice more frequently in women compared to men 
and is in the moderate risk group according to the Soft Tissue 
Neoplasia classification of the World Health Organization (4). 
The tumor biology exhibits a local aggressive course and it 
does not cause distant organ metastasis. It is usually observed 
in the intra-abdominal region and is rarely reported in an intra-
thoracic location (5). Desmoid fibromatosis may develop on a 
hereditary basis (familial adenomatosis polyposis syndrome) 
and such acquired reasons as trauma, history of surgical 
procedure, laceration and intramuscular injection may also 
increase risk of incidence (6). 
Thoracic desmoid tumors emerge following mastectomy, 
silicon prosthesis implant to the breast, rib fractures in 
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coronary artery surgery and thoracotomy (7). The present 
patient is the second case following breast cancer surgery 
reported in literature, and the silicon implantation following 
mastectomy in the first case constituted an additional risk 
factor and therefore differs from the present case (8).
Desmoid tumors arise as palpable masses causing pain, as 
in the present case. Neurofibromatosis, ganglioneuroma, fibro-
sarcoma, fibrous tumor and lung cancer must be considered 
in differential diagnosis (7). By contrast, in the present case, a 
breast cancer metastasis was primarily considered due to the 
history of breast cancer and a fine needle aspiration biopsy 
was applied. Metastasis was eliminated and the mass was 
diagnosed as a desmoid tumor as a result of the biopsy and 
subsequently en-block excision of the mass was performed.
The primary treatment for desmoid tumors is surgical 
resection; however, radiotherapy should also be added to 
treatment in the event of incomplete surgery, large tumors, 
relapses and inoperable cases (9). Radiotherapy was added to 
the treatment in the present case due to close surgical margins. 
Non-steroid anti-inflammatory agents (10), and hormonal 
therapy, also including tamoxifen (11), and imatinib (12), have 
been recommended in the literature. As the sample from the 
present case was immunohistochemically stained CD117(+), 
maintenance imatinib treatment was started upon the comple-
tion of radiotherapy, which was consistent with a previous 
study (12).
In conclusion, desmoid tumors should be considered in 
patients with a history of surgical intervention. They should 
also be considered in a differential diagnosis when local 
relapse and metastasis is suspected, particularly following 
breast cancer surgery.
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Figure 1. Computed tomography reveals a 44x22 mm mass in the 7th and 8th 
right intercostal spaces (lung window; arrows).
Figure 2. Axial section computed tomography scan. The arrows highlight a 
soft tissue density (bone window).
Figure 3 (A) Cellular proliferation of bland spindle cells arranged in long 
sweeping bundles (haematoxylin and eosin stain; magnification, x10). 
(B) Occasional tumor cells showed nuclear positivity for cluster of differen-
tiation 117 (immunohistochemistry; magnification, x20). 
